Rise Life Science Corp (RLSC.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
(Values in thousands)
| 11-2020 | 11-2019 | 11-2018 | 11-2017 | 11-2016 | |
| Sales | 32 | 974 | 186 | 0 | 0 |
| Cost of Goods | 12 | 636 | 49 | N/A | N/A |
| Gross Profit | 20 | 338 | 137 | N/A | N/A |
| Operating Expenses | 1,031 | 5,543 | 5,431 | 1,993 | 577 |
| Operating Income | -1,011 | -5,205 | -5,295 | -1,993 | -577 |
| Interest Expense | 1,517 | 1,719 | 448 | 319 | 325 |
| Other Income | -676 | -203 | -6,114 | -74 | -206 |
| Pre-tax Income | -3,204 | -7,127 | -11,856 | -2,387 | -1,109 |
| Net Income Continuous | -3,204 | -7,127 | -11,856 | -2,387 | -1,109 |
| Net Income | $-3,204 | $-7,127 | $-11,856 | $-2,387 | $-1,109 |
| EPS Basic Total Ops | -0.50 | -1.20 | -2.40 | -1.80 | -5.00 |
| EPS Basic Continuous Ops | -0.50 | -1.20 | -2.40 | -1.80 | -5.00 |
| EPS Diluted Total Ops | -0.50 | -1.20 | -2.40 | -1.80 | -5.00 |
| EPS Diluted Continuous Ops | -0.50 | -1.20 | -2.40 | -1.80 | -5.00 |
| EBITDA(a) | $-1,618 | $-5,355 | $-11,105 | $-2,024 | $-763 |